Corresponding Author definition

Corresponding Author. An Author jointly chosen and appointed by all the Authors to manage, also on their behalf, the relationship with the Publisher and the relevant publishing process, including (without limitation) the following activities: managing all communications between the Publisher and the Authors during the Manuscript submission, peer review, publication process and after publication; ensuring that the names of the Authors, their arrangement and affiliations are correct; ensuring that all the Authors have approved the manuscript before submission; making sure and warranting that all permissions to reproduce previously published material have been obtained from the relevant owners or licensees; making sure disclosures, declarations, statements from all the Authors are included in the manuscript; executing all deeds, agreements and undertakings concerning the Manuscript.
Sample 1Sample 2Sample 3
Corresponding Author. “I” and “You” means the author who is a signatory to this Agreement; “Authors” “We”, “Our” “They” means all the authors mentioned on the first page of this Agreement; “Co-Authors” mean all the authors mentioned on the first page of this Agreement except the Corresponding Author. “Journal” means the Journal specified on the first page of this Agreement, “Publisher” or “Publishers” means Edorium™, its owners, licensees, assignees and successors in business. In submitting the above mentioned Manuscript to the Journal, I (Insert name of Corresponding Author), the Corresponding Author of the above specified Manuscript; certify that I am authorized by all Co-Authors to enter into the agreement given below. On behalf of myself and my Co-Authors, I certify that:
Sample 1
Corresponding Author means the Eligible Author that submits a manuscript to [INSERT Product Name]; and is the author responsible for communicating with the journal during the submission, peer review and publication process.
Sample 1

Examples of Corresponding Author in a sentence

  • After submission of the Consent to Publish form signed by the Corresponding Author, changes of authorship, or in the order of the authors listed, will not be accepted by the Publisher.

  • If the Publisher is the terminating Party the notice need only be provided to the address of the Corresponding Author.

  • In the event of co-authors having entered into this Agreement the Publisher shall send the page proofs to the Corresponding Author only and all persons entering into this Agreement as Author agree that the Corresponding Author shall correct and approve the page proofs on their behalf.

  • Signature of Corresponding Author: Date: ………………………………………………………… ………………………………………..

  • The Corresponding Author shall disclose, in Schedule 1: Details of the Work, details relating to all actual or potential conflicts of interest relating to the Work, and all financial contributions relevant to the Work and its publication pursuant to this Agreement.

  • Upon request from Xxxxxxx Open, the Corresponding Author shall at his/her own expense provide written evidence of the same to Xxxxxxx Open.

  • If requested by Xxxxxxx Open, the Corresponding Author shall provide Xxxxxxx Open with any further information Xxxxxxx Open may request in respect of such matters.

  • The parties agree that, at a minimum, and subject to the payment of the Fee by the Corresponding Author (as set out in Schedule 3: Publishing) and the other terms of this Agreement, the Work shall be published in the manner specified, and on the commercial terms specified, in Schedule 3: Publishing.

  • The Corresponding Author represents and warrants that he or she has full right and power to enter into this Agreement, and (where the Corresponding Author is not the sole author) that the Author/s of the Work consent and agree to the terms of this Agreement and have irrevocably granted all rights in the Work to the Corresponding Author in order to allow Xxxxxxx Open to publish the Work in accordance with the terms of this Agreement.

  • The Corresponding Author shall pay the Fee to Xxxxxxx Open within 15 days of the date of invoice by means of cheque made payable to “Xxxxxxx Open Publishers Ltd”, or by credit card payment or by bank wire transfer.


More Definitions of Corresponding Author

Corresponding Author. Xxxxxxx Xxxxxx-Xxxxxxx, Department of Psychology (P77), Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK. Tel: +00 00 00000000 Fax: +00 00 00000000. E-mail: x.xxxxxx-xxxxxxx@xxx.xxx.xx.xx The authors thank Xxxxxx Xxxxx and other staff at King’s College Hospital, London, for support in recruiting participants and Xx. Xxxx Xxxxxx for training given to Xx. Xxxxxx- Xxxxxxx. We are grateful for the comments of three anonymous reviewers.
Sample 1
Corresponding Author is defined for this agreement as the author who is listed as the corresponding author in the article.
Sample 1
Corresponding Author. To be published in the Journal: Annalen des Naturhistorischen Museums in Wien ☐ Serie A ☐ Serie B Conditions
Sample 1
Corresponding Author means an author of a manuscript authorized by all co-authors to act as an agent on their behalf in all matters pertaining to publication of the manuscript;
Sample 1
Corresponding Author. (if more than one author) ........................................................................................................................... Journal Name Publications IG, PAS ...........................................................................................................................
Sample 1

Related to Corresponding Author

  • Corresponding Component As identified in the Preliminary Statement with respect to any Class of Non-Vertically Retained Principal Balance Certificates or Lower-Tier Regular Interest.

  • Corresponding Tenor with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor.

  • corresponding law means a law of another State, Territory or New Zealand that provides for the same matter as a relevant Act or a provision of a relevant Act.

  • Combination Product means (a) a product containing a Licensed Product together with one or more other active ingredients that have independent biologic or chemical activity when present alone that are sold as a single unit, or (b) a Licensed Product together with one or more products, devices, pieces of equipment or components thereof, that are sold as a single package at a single price.

  • Regulatory Filing means any approvals, licenses, registrations, submissions and authorizations, and applications therefor, including IND, NDA, BLA, drug dossier or drug master file filed, or Marketing Approval obtained, with respect to an Option Product, Licensed Product or Companion Diagnostic, as applicable, in the Field, including all amendments, supplements, annual reports and the like thereof or therefor filed with or otherwise provided to the applicable Regulatory Authority.

  • Additional Indication means any indication other than the Initial Indication.

  • Regulatory Materials means regulatory applications, submissions, notifications, registrations, or other filings made to or with a Regulatory Authority that are necessary or reasonably desirable in order to develop, manufacture, market, sell or otherwise commercialize a product in a particular country or regulatory jurisdiction. Regulatory Materials include INDs, XXXx and NDAs (as applications, but not the approvals with respect thereto).

  • Combination Products means any product containing both a pharmaceutically active agent or ingredient which constitutes a Licensed Product and one or more other pharmaceutically active agents or ingredients which do not constitute Licensed Products.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Marketing Authorization means all approvals from the relevant Regulatory Authority necessary to market and sell a Product in any country (including without limitation all applicable pricing and governmental reimbursement approvals even if not legally required to sell Product in a country).

  • Additional SDU Study means a deliverability study that a Developer may elect to pursue as that term is defined in OATT Section 25 (OATT Attachment S). For purposes of Section 23.4.5 of this Attachment H, “Affiliated Entity” shall mean, with respect to a person or Entity:

  • Alternative nicotine product means any vaping product, whether or not it includes nicotine, including electronic smoking devices, that can be ingested into the body by chewing, smoking, absorbing, dissolving, inhaling, or by any other means. ‘Alternative nicotine product’ does not include:

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing, and control data, preclinical data, clinical data or all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product in the Field (including any Drug Master Files (DMFs), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Derivative Product means a written contract or agreement between the Authority and a Reciprocal Payor, which provides that the Authority’s obligations thereunder will be conditioned on the absence of (a) a failure by the Reciprocal Payor to make any payment required thereunder when due and payable, or (b) a default thereunder with respect to the financial status of the Reciprocal Payor; and:

  • Investment product means a financial instrument (within the meaning of Article 4(1)(15) of MiFID II) or a structured deposit (within the meaning of Article 4(1)(43) of MiFID II).

  • Corresponding Certificate With respect to each REMIC II Regular Interest (other than REMIC II Regular Interests AA, ZZ and IO), the Certificate with the corresponding designation. With respect to each REMIC III Regular Interest (other than the Class C Interest and the Class IO Interest), the related Certificate representing an ownership therein.

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.

  • distributed ledger technology means a database system in which—

  • Controlled technical information means technical information with military or space application that is subject to controls on the access, use, reproduction, modification, performance, display, release, disclosure, or dissemination. Controlled technical information would meet the criteria, if disseminated, for distribution statements B through F using the criteria set forth in DoD Instruction 5230.24, Distribution Statements on Technical Documents. The term does not include information that is lawfully publicly available without restrictions.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Regulatory Filings means any submission to a Regulatory Authority of any appropriate regulatory application together with any related correspondence and documentation, and will include any submission to a regulatory advisory board, marketing authorization application, and any supplement or amendment thereto.

  • Commercial Product means any such product as defined in FAR 2.101.

  • Research Results means any technical result acquired based on the Collaborative Research, including, but not limited to, any invention, idea, design, copyrightable work and know-how which relates to the purpose of the Collaborative Research.

  • Existing Product means any formulation of the same product category and form sold, supplied, manufactured, or offered for sale in California prior to the following dates, or any subsequently introduced identical formulation:

  • Regulatory Approval Application means an application to seek regular or expedited Regulatory Approval of the Licensed Product for sale or marketing in any country(ies) or Region(s) in the Territory, as defined in the applicable Laws and filed with the Regulatory Authority of such country(ies) or Region(s).